| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurocysticercosis | 23 | 2016 | 29 | 5.740 |
Why?
|
| Mesocestoides | 19 | 2013 | 23 | 3.050 |
Why?
|
| Tularemia | 10 | 2013 | 115 | 2.060 |
Why?
|
| B-Lymphocytes | 39 | 2011 | 183 | 1.860 |
Why?
|
| Francisella tularensis | 8 | 2011 | 116 | 1.650 |
Why?
|
| Francisella | 5 | 2011 | 20 | 1.620 |
Why?
|
| Mice | 86 | 2016 | 6490 | 1.400 |
Why?
|
| Brain | 14 | 2013 | 1452 | 1.390 |
Why?
|
| Cytokines | 18 | 2013 | 661 | 1.360 |
Why?
|
| Brain Diseases | 6 | 2012 | 31 | 1.310 |
Why?
|
| Mice, Inbred BALB C | 42 | 2016 | 686 | 1.280 |
Why?
|
| Lung Diseases | 4 | 2011 | 62 | 1.230 |
Why?
|
| Macrophages | 12 | 2011 | 515 | 1.180 |
Why?
|
| Genes, Immunoglobulin | 11 | 1998 | 37 | 1.110 |
Why?
|
| T-Lymphocytes | 21 | 2011 | 378 | 1.080 |
Why?
|
| Animals | 96 | 2016 | 16695 | 1.020 |
Why?
|
| Macrophage Activation | 3 | 2011 | 59 | 0.990 |
Why?
|
| Sepsis | 4 | 2013 | 90 | 0.990 |
Why?
|
| Immunoglobulin Heavy Chains | 10 | 2001 | 57 | 0.970 |
Why?
|
| Gram-Negative Bacterial Infections | 3 | 2010 | 28 | 0.970 |
Why?
|
| Mice, Inbred C57BL | 23 | 2016 | 1804 | 0.940 |
Why?
|
| Antigens, Helminth | 9 | 2008 | 34 | 0.920 |
Why?
|
| Toll-Like Receptors | 4 | 2009 | 51 | 0.920 |
Why?
|
| Cestode Infections | 8 | 2011 | 8 | 0.900 |
Why?
|
| Blood-Brain Barrier | 4 | 2013 | 167 | 0.820 |
Why?
|
| Immunoglobulin Variable Region | 11 | 1998 | 22 | 0.770 |
Why?
|
| Antibody Diversity | 10 | 2001 | 11 | 0.680 |
Why?
|
| Disease Models, Animal | 15 | 2013 | 1554 | 0.670 |
Why?
|
| Up-Regulation | 5 | 2011 | 534 | 0.670 |
Why?
|
| Ependyma | 2 | 2012 | 5 | 0.660 |
Why?
|
| Lung | 12 | 2013 | 484 | 0.650 |
Why?
|
| Aging | 7 | 2010 | 764 | 0.630 |
Why?
|
| Phagocytosis | 3 | 2010 | 83 | 0.610 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2009 | 181 | 0.600 |
Why?
|
| Pneumonia, Bacterial | 2 | 2009 | 24 | 0.590 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 683 | 0.590 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2009 | 276 | 0.580 |
Why?
|
| Spleen | 20 | 2011 | 199 | 0.580 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 4 | 2003 | 17 | 0.570 |
Why?
|
| Bacterial Vaccines | 2 | 2009 | 129 | 0.570 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2001 | 53 | 0.530 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2011 | 29 | 0.510 |
Why?
|
| Immune Tolerance | 13 | 2001 | 67 | 0.490 |
Why?
|
| Female | 43 | 2016 | 24018 | 0.480 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2011 | 64 | 0.480 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 1066 | 0.470 |
Why?
|
| Taenia solium | 4 | 2009 | 5 | 0.470 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 6 | 1998 | 11 | 0.450 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2009 | 26 | 0.440 |
Why?
|
| Taenia | 6 | 2010 | 6 | 0.430 |
Why?
|
| Membrane Proteins | 2 | 2007 | 548 | 0.410 |
Why?
|
| Th1 Cells | 5 | 2002 | 97 | 0.410 |
Why?
|
| Immunoglobulin Isotypes | 6 | 1991 | 17 | 0.410 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2013 | 3 | 0.400 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2011 | 24 | 0.400 |
Why?
|
| Mannose-Binding Lectins | 1 | 2013 | 14 | 0.400 |
Why?
|
| Blood Vessels | 1 | 2013 | 36 | 0.400 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2009 | 15 | 0.400 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 37 | 0.390 |
Why?
|
| Mice, Knockout | 7 | 2013 | 1010 | 0.380 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 146 | 0.380 |
Why?
|
| Complementarity Determining Regions | 4 | 2001 | 8 | 0.370 |
Why?
|
| Calgranulin B | 2 | 2009 | 4 | 0.370 |
Why?
|
| Bacteremia | 2 | 2011 | 37 | 0.370 |
Why?
|
| Peptide Elongation Factor Tu | 1 | 2011 | 2 | 0.350 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 221 | 0.350 |
Why?
|
| STAT6 Transcription Factor | 1 | 2010 | 17 | 0.340 |
Why?
|
| Multigene Family | 6 | 1992 | 105 | 0.340 |
Why?
|
| Th2 Cells | 3 | 2002 | 63 | 0.330 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2002 | 91 | 0.330 |
Why?
|
| Immunoglobulin Joining Region | 3 | 1997 | 4 | 0.330 |
Why?
|
| Lymphocyte Activation | 15 | 2001 | 244 | 0.310 |
Why?
|
| Glycoproteins | 4 | 2003 | 127 | 0.310 |
Why?
|
| Doxycycline | 1 | 2009 | 32 | 0.300 |
Why?
|
| Liver | 11 | 2011 | 503 | 0.300 |
Why?
|
| Helminthiasis | 1 | 2009 | 4 | 0.300 |
Why?
|
| Protozoan Infections | 1 | 2009 | 4 | 0.300 |
Why?
|
| Central Nervous System Infections | 1 | 2009 | 4 | 0.300 |
Why?
|
| Glycoconjugates | 2 | 2008 | 6 | 0.300 |
Why?
|
| Cysticercosis | 3 | 2012 | 3 | 0.290 |
Why?
|
| Immunoglobulin G | 9 | 2011 | 253 | 0.280 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 49 | 0.280 |
Why?
|
| HMGB1 Protein | 1 | 2008 | 30 | 0.280 |
Why?
|
| Immunoglobulin M | 8 | 1998 | 87 | 0.280 |
Why?
|
| Immunoglobulin kappa-Chains | 3 | 1993 | 9 | 0.280 |
Why?
|
| Apoptosis | 3 | 2010 | 1541 | 0.270 |
Why?
|
| Microcirculation | 1 | 2007 | 40 | 0.270 |
Why?
|
| Intercellular Junctions | 1 | 2007 | 18 | 0.270 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 24 | 0.270 |
Why?
|
| Antibodies, Helminth | 2 | 2001 | 24 | 0.270 |
Why?
|
| B-Lymphocyte Subsets | 4 | 1998 | 16 | 0.270 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2001 | 47 | 0.270 |
Why?
|
| Embryonic and Fetal Development | 5 | 1989 | 33 | 0.260 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 457 | 0.260 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2013 | 196 | 0.250 |
Why?
|
| Survival Analysis | 4 | 2013 | 362 | 0.250 |
Why?
|
| Cerebrospinal Fluid | 1 | 2006 | 20 | 0.240 |
Why?
|
| Microscopy, Fluorescence | 3 | 2013 | 254 | 0.240 |
Why?
|
| Encephalitis | 2 | 2007 | 43 | 0.240 |
Why?
|
| Cestoda | 3 | 2012 | 3 | 0.230 |
Why?
|
| Fetus | 10 | 1998 | 101 | 0.230 |
Why?
|
| Interleukin-4 | 5 | 2001 | 75 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 382 | 0.220 |
Why?
|
| Antibody Formation | 10 | 1991 | 75 | 0.220 |
Why?
|
| Ultrasonography | 3 | 1989 | 132 | 0.220 |
Why?
|
| Heat-Shock Proteins | 3 | 1993 | 59 | 0.210 |
Why?
|
| Cell Differentiation | 12 | 1991 | 633 | 0.200 |
Why?
|
| Chemokines, CC | 1 | 2003 | 53 | 0.200 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 1 | 0.190 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 708 | 0.190 |
Why?
|
| Leukocytes | 2 | 2016 | 79 | 0.190 |
Why?
|
| Leishmania donovani | 1 | 2001 | 18 | 0.180 |
Why?
|
| Taeniasis | 1 | 2001 | 1 | 0.180 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2001 | 17 | 0.180 |
Why?
|
| Immunoglobulin Allotypes | 4 | 1986 | 5 | 0.180 |
Why?
|
| Granuloma | 1 | 2001 | 24 | 0.180 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 5 | 2002 | 12 | 0.170 |
Why?
|
| Epitopes | 10 | 2003 | 155 | 0.170 |
Why?
|
| Arginase | 2 | 2011 | 14 | 0.170 |
Why?
|
| RNA, Messenger | 5 | 2008 | 1265 | 0.170 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2011 | 54 | 0.170 |
Why?
|
| Inflammation | 4 | 2011 | 729 | 0.170 |
Why?
|
| Clone Cells | 12 | 1989 | 50 | 0.160 |
Why?
|
| Carbohydrates | 1 | 2000 | 32 | 0.160 |
Why?
|
| Animals, Newborn | 8 | 1990 | 350 | 0.160 |
Why?
|
| Cell Movement | 4 | 2008 | 640 | 0.160 |
Why?
|
| Humans | 25 | 2012 | 42163 | 0.160 |
Why?
|
| Inflammation Mediators | 2 | 2011 | 138 | 0.160 |
Why?
|
| Central Nervous System | 2 | 2012 | 150 | 0.150 |
Why?
|
| Colony Count, Microbial | 2 | 2009 | 67 | 0.150 |
Why?
|
| Eosinophilia | 2 | 2016 | 16 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2011 | 456 | 0.150 |
Why?
|
| Neutrophil Infiltration | 2 | 2009 | 28 | 0.150 |
Why?
|
| Time Factors | 7 | 2008 | 1848 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 7 | 1986 | 21 | 0.140 |
Why?
|
| Gene Expression | 6 | 2006 | 692 | 0.140 |
Why?
|
| Antibodies | 6 | 1979 | 140 | 0.140 |
Why?
|
| Azo Compounds | 3 | 1984 | 17 | 0.140 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 1987 | 45 | 0.130 |
Why?
|
| Lipopolysaccharides | 7 | 1993 | 235 | 0.130 |
Why?
|
| Reading Frames | 1 | 1997 | 2 | 0.130 |
Why?
|
| Serum Albumin, Bovine | 4 | 1978 | 49 | 0.130 |
Why?
|
| Immunoglobulin Class Switching | 1 | 1997 | 20 | 0.130 |
Why?
|
| Recombination, Genetic | 1 | 1997 | 96 | 0.130 |
Why?
|
| Plasma Cells | 4 | 1992 | 11 | 0.130 |
Why?
|
| DNA Fingerprinting | 3 | 2002 | 17 | 0.130 |
Why?
|
| Gene Deletion | 1 | 1997 | 168 | 0.130 |
Why?
|
| Astrocytes | 3 | 2008 | 244 | 0.130 |
Why?
|
| Lymphocyte Count | 3 | 2009 | 47 | 0.130 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1995 | 200 | 0.120 |
Why?
|
| Antigens | 5 | 1983 | 58 | 0.120 |
Why?
|
| Mice, Inbred CBA | 8 | 1989 | 41 | 0.120 |
Why?
|
| Kinetics | 7 | 2009 | 698 | 0.120 |
Why?
|
| Interleukin-6 | 2 | 2011 | 165 | 0.120 |
Why?
|
| Neuromuscular Junction | 1 | 1995 | 34 | 0.120 |
Why?
|
| Molecular Sequence Data | 7 | 2003 | 1559 | 0.110 |
Why?
|
| Immunoglobulin A | 2 | 2011 | 63 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2002 | 1266 | 0.110 |
Why?
|
| Base Sequence | 5 | 1998 | 997 | 0.110 |
Why?
|
| Immunity, Cellular | 3 | 2001 | 73 | 0.110 |
Why?
|
| Immune Sera | 3 | 2011 | 56 | 0.100 |
Why?
|
| Immunoglobulin Idiotypes | 4 | 1988 | 4 | 0.100 |
Why?
|
| Neutrophils | 2 | 2016 | 141 | 0.100 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 1993 | 1 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 4 | 2002 | 454 | 0.100 |
Why?
|
| p-Aminoazobenzene | 2 | 1984 | 2 | 0.100 |
Why?
|
| Cyclopentanes | 1 | 1993 | 23 | 0.100 |
Why?
|
| Galectin 3 | 1 | 2013 | 29 | 0.100 |
Why?
|
| Coloring Agents | 2 | 1984 | 56 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 85 | 0.100 |
Why?
|
| Microscopy | 1 | 2013 | 33 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2013 | 64 | 0.100 |
Why?
|
| Exons | 1 | 1993 | 91 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 36 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2013 | 50 | 0.100 |
Why?
|
| HIV Infections | 3 | 2002 | 2535 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 70 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 727 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2012 | 31 | 0.100 |
Why?
|
| Dinitrobenzenes | 7 | 1990 | 17 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2003 | 884 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 658 | 0.090 |
Why?
|
| Immune System | 1 | 2012 | 40 | 0.090 |
Why?
|
| Interleukin-12 | 2 | 2004 | 46 | 0.090 |
Why?
|
| Lymphocyte Depletion | 2 | 2009 | 13 | 0.090 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 2002 | 4 | 0.090 |
Why?
|
| Autoimmunity | 1 | 1992 | 56 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2004 | 415 | 0.090 |
Why?
|
| Immunoglobulin delta-Chains | 1 | 1991 | 1 | 0.090 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1991 | 3 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 310 | 0.090 |
Why?
|
| Immunodominant Epitopes | 1 | 2011 | 28 | 0.090 |
Why?
|
| Genes, T-Cell Receptor delta | 2 | 2002 | 5 | 0.090 |
Why?
|
| Interferon-gamma | 3 | 2004 | 268 | 0.090 |
Why?
|
| Immunity, Humoral | 1 | 2011 | 26 | 0.090 |
Why?
|
| Adult | 10 | 2001 | 13458 | 0.090 |
Why?
|
| Lectins | 2 | 2008 | 19 | 0.080 |
Why?
|
| Microglia | 2 | 2011 | 204 | 0.080 |
Why?
|
| Models, Immunological | 1 | 2010 | 21 | 0.080 |
Why?
|
| Virulence | 1 | 2011 | 238 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 100 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 1998 | 1188 | 0.080 |
Why?
|
| Necrosis | 1 | 2010 | 54 | 0.080 |
Why?
|
| Cell Culture Techniques | 2 | 2001 | 151 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1991 | 255 | 0.080 |
Why?
|
| Swine | 2 | 2008 | 205 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2009 | 2111 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2011 | 411 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 1993 | 599 | 0.080 |
Why?
|
| Cell Survival | 2 | 2010 | 934 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2009 | 31 | 0.080 |
Why?
|
| Animal Structures | 1 | 2009 | 21 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2009 | 1 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 522 | 0.080 |
Why?
|
| Lupus Nephritis | 1 | 1989 | 26 | 0.080 |
Why?
|
| Annexin A5 | 1 | 2009 | 27 | 0.080 |
Why?
|
| Vaccines, Attenuated | 1 | 2009 | 75 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2002 | 246 | 0.080 |
Why?
|
| Immunoglobulin alpha-Chains | 2 | 1998 | 4 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 649 | 0.080 |
Why?
|
| Growth Substances | 1 | 1988 | 16 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 203 | 0.080 |
Why?
|
| Copper Radioisotopes | 1 | 2008 | 9 | 0.070 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 117 | 0.070 |
Why?
|
| Middle Aged | 6 | 2001 | 11819 | 0.070 |
Why?
|
| Whole Body Imaging | 1 | 2008 | 25 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 379 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2011 | 400 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2008 | 106 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2003 | 928 | 0.070 |
Why?
|
| Leukocytosis | 1 | 2008 | 2 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 2 | 2001 | 214 | 0.070 |
Why?
|
| Immune Evasion | 1 | 2008 | 17 | 0.070 |
Why?
|
| Blood | 1 | 2008 | 37 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 93 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2008 | 67 | 0.070 |
Why?
|
| Male | 9 | 2009 | 22779 | 0.070 |
Why?
|
| Phenotype | 1 | 2010 | 774 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 160 | 0.070 |
Why?
|
| Pia Mater | 1 | 2007 | 5 | 0.070 |
Why?
|
| Adherens Junctions | 1 | 2007 | 11 | 0.070 |
Why?
|
| Choroid Plexus | 1 | 2007 | 6 | 0.070 |
Why?
|
| Parasites | 1 | 2008 | 36 | 0.070 |
Why?
|
| DNA Primers | 3 | 2013 | 295 | 0.070 |
Why?
|
| Tight Junctions | 1 | 2007 | 27 | 0.070 |
Why?
|
| Cell Line | 2 | 2008 | 1416 | 0.070 |
Why?
|
| Immunoglobulins | 3 | 1982 | 39 | 0.070 |
Why?
|
| Haptens | 5 | 1989 | 20 | 0.070 |
Why?
|
| Brain Edema | 1 | 2007 | 64 | 0.070 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2006 | 3 | 0.060 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2006 | 5 | 0.060 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2006 | 4 | 0.060 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2006 | 9 | 0.060 |
Why?
|
| Cysticercus | 2 | 2003 | 2 | 0.060 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2006 | 6 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 261 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 95 | 0.060 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2006 | 11 | 0.060 |
Why?
|
| Indoles | 1 | 2008 | 178 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2007 | 129 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2007 | 462 | 0.060 |
Why?
|
| Leukocyte Count | 2 | 2001 | 68 | 0.060 |
Why?
|
| Capillary Permeability | 1 | 2006 | 36 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 1984 | 84 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1990 | 71 | 0.060 |
Why?
|
| Binding Sites, Antibody | 4 | 1998 | 19 | 0.060 |
Why?
|
| Gestational Age | 4 | 1998 | 195 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 117 | 0.050 |
Why?
|
| Fishes | 1 | 1984 | 59 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 1984 | 53 | 0.050 |
Why?
|
| Chemokine CCL3 | 1 | 2003 | 14 | 0.050 |
Why?
|
| Chemokine CCL4 | 1 | 2003 | 19 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2002 | 50 | 0.050 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2003 | 16 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 198 | 0.050 |
Why?
|
| Lymphocyte Cooperation | 4 | 1987 | 5 | 0.050 |
Why?
|
| Mice, Inbred A | 3 | 1989 | 7 | 0.050 |
Why?
|
| Helminth Proteins | 1 | 2003 | 23 | 0.050 |
Why?
|
| Chromatography, Affinity | 2 | 2000 | 67 | 0.050 |
Why?
|
| Leukopenia | 1 | 2002 | 10 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2003 | 70 | 0.050 |
Why?
|
| Hobbies | 1 | 1982 | 2 | 0.050 |
Why?
|
| Transplantation, Autologous | 2 | 1999 | 7 | 0.050 |
Why?
|
| Brain Chemistry | 2 | 2002 | 140 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2003 | 95 | 0.050 |
Why?
|
| Molecular Weight | 3 | 2003 | 168 | 0.050 |
Why?
|
| Mesocricetus | 1 | 2001 | 56 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2002 | 429 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2001 | 16 | 0.040 |
Why?
|
| Mice, Inbred Strains | 3 | 1992 | 116 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 111 | 0.040 |
Why?
|
| Neurons | 1 | 2008 | 1246 | 0.040 |
Why?
|
| Oligosaccharides | 1 | 2001 | 28 | 0.040 |
Why?
|
| Bone Marrow | 2 | 1993 | 35 | 0.040 |
Why?
|
| Cricetinae | 1 | 2001 | 241 | 0.040 |
Why?
|
| Dinitrophenols | 3 | 1989 | 6 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2001 | 28 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 1981 | 59 | 0.040 |
Why?
|
| Organ Culture Techniques | 3 | 1988 | 102 | 0.040 |
Why?
|
| Cell Separation | 5 | 1982 | 94 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2001 | 130 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2002 | 452 | 0.040 |
Why?
|
| Mast Cells | 2 | 2016 | 83 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 1980 | 50 | 0.040 |
Why?
|
| Nitrobenzenes | 4 | 1983 | 19 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 301 | 0.040 |
Why?
|
| Immunologic Memory | 5 | 1986 | 41 | 0.040 |
Why?
|
| Glycosylation | 1 | 2000 | 111 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 1989 | 1617 | 0.040 |
Why?
|
| Transplantation Conditioning | 1 | 1999 | 8 | 0.040 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 1999 | 3 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 1979 | 64 | 0.040 |
Why?
|
| Models, Biological | 2 | 1998 | 711 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 4 | 1983 | 25 | 0.040 |
Why?
|
| Autoantigens | 1 | 1979 | 85 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 1998 | 37 | 0.040 |
Why?
|
| Meninges | 1 | 1998 | 6 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2001 | 1679 | 0.040 |
Why?
|
| Granulocytes | 1 | 1998 | 26 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1998 | 66 | 0.040 |
Why?
|
| Larva | 1 | 1999 | 131 | 0.040 |
Why?
|
| Genes, T-Cell Receptor | 1 | 1998 | 3 | 0.040 |
Why?
|
| Binding Sites | 1 | 2000 | 670 | 0.040 |
Why?
|
| p-Azobenzenearsonate | 1 | 1978 | 1 | 0.040 |
Why?
|
| Species Specificity | 2 | 1989 | 279 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 1998 | 90 | 0.040 |
Why?
|
| HIV-1 | 2 | 2001 | 747 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 1998 | 86 | 0.040 |
Why?
|
| Stem Cells | 2 | 1989 | 151 | 0.040 |
Why?
|
| Biopsy | 1 | 1998 | 176 | 0.030 |
Why?
|
| 2,4-Dinitrophenol | 2 | 1989 | 4 | 0.030 |
Why?
|
| Abelson murine leukemia virus | 1 | 1997 | 1 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 96 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 271 | 0.030 |
Why?
|
| Autoantibodies | 2 | 1992 | 112 | 0.030 |
Why?
|
| Neural Conduction | 1 | 1995 | 17 | 0.030 |
Why?
|
| Glutathione | 1 | 1976 | 170 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 1998 | 960 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 1998 | 475 | 0.030 |
Why?
|
| Poly A | 2 | 1991 | 33 | 0.030 |
Why?
|
| Age Factors | 3 | 1990 | 1139 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 45 | 0.030 |
Why?
|
| Brefeldin A | 1 | 1993 | 4 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1993 | 27 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 134 | 0.030 |
Why?
|
| Omentum | 1 | 1993 | 5 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2002 | 3077 | 0.030 |
Why?
|
| Action Potentials | 1 | 1995 | 246 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1986 | 12 | 0.030 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1993 | 2 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 138 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 1983 | 80 | 0.020 |
Why?
|
| Immunoglobulin D | 3 | 1982 | 6 | 0.020 |
Why?
|
| Cross Reactions | 2 | 1986 | 86 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1993 | 99 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1992 | 4 | 0.020 |
Why?
|
| Antibody-Producing Cells | 2 | 1983 | 6 | 0.020 |
Why?
|
| Hemolytic Plaque Technique | 2 | 1983 | 6 | 0.020 |
Why?
|
| Peptide Fragments | 3 | 1978 | 301 | 0.020 |
Why?
|
| Protein Conformation | 3 | 1977 | 420 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1991 | 36 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 1990 | 5 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1991 | 152 | 0.020 |
Why?
|
| Neoplasms | 1 | 1982 | 1341 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 1990 | 8 | 0.020 |
Why?
|
| Immunization | 1 | 1991 | 93 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1991 | 205 | 0.020 |
Why?
|
| Lymphokines | 1 | 1990 | 17 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1990 | 23 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 33 | 0.020 |
Why?
|
| Rabbits | 2 | 1981 | 292 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2009 | 5 | 0.020 |
Why?
|
| Cell Fractionation | 2 | 1980 | 30 | 0.020 |
Why?
|
| DNA | 1 | 1993 | 594 | 0.020 |
Why?
|
| Interphase | 1 | 1989 | 6 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1989 | 21 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 1989 | 17 | 0.020 |
Why?
|
| Immunologic Techniques | 2 | 1978 | 12 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 115 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 1989 | 101 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 1988 | 19 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1987 | 9 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 1987 | 8 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1976 | 20 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1987 | 68 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 1986 | 8 | 0.020 |
Why?
|
| Amino Acids | 2 | 1977 | 150 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2001 | 1586 | 0.010 |
Why?
|
| Gentamicins | 1 | 2004 | 10 | 0.010 |
Why?
|
| Cytochalasins | 1 | 1984 | 1 | 0.010 |
Why?
|
| Immunologic Capping | 1 | 1984 | 2 | 0.010 |
Why?
|
| Tubercidin | 1 | 1984 | 4 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 1984 | 6 | 0.010 |
Why?
|
| Colchicine | 1 | 1984 | 15 | 0.010 |
Why?
|
| Cytarabine | 1 | 1984 | 10 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2004 | 89 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 1984 | 34 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1983 | 5 | 0.010 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 1 | 2003 | 10 | 0.010 |
Why?
|
| Antibody Specificity | 2 | 1982 | 76 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 2003 | 75 | 0.010 |
Why?
|
| Protein Binding | 2 | 1976 | 1076 | 0.010 |
Why?
|
| Papilloma | 1 | 1982 | 17 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2002 | 44 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 2001 | 20 | 0.010 |
Why?
|
| Ascaris | 1 | 1981 | 2 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 602 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2001 | 73 | 0.010 |
Why?
|
| Isoantigens | 1 | 1980 | 5 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1980 | 47 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2001 | 229 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1980 | 136 | 0.010 |
Why?
|
| gamma-Globulins | 1 | 1979 | 5 | 0.010 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1979 | 12 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1999 | 21 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1999 | 57 | 0.010 |
Why?
|
| Sex Factors | 1 | 1983 | 1008 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1978 | 23 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1979 | 124 | 0.010 |
Why?
|
| Recurrence | 1 | 1999 | 149 | 0.010 |
Why?
|
| Immunoassay | 1 | 1978 | 69 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 314 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 233 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1998 | 48 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 195 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1977 | 64 | 0.010 |
Why?
|
| Body Weight | 1 | 1999 | 428 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1978 | 348 | 0.010 |
Why?
|
| Trypsin | 1 | 1976 | 40 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1976 | 95 | 0.010 |
Why?
|
| Disulfides | 1 | 1976 | 92 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1976 | 184 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1976 | 448 | 0.010 |
Why?
|
| Pregnancy | 1 | 1979 | 1737 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1999 | 979 | 0.010 |
Why?
|
| Hybridomas | 1 | 1990 | 24 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1990 | 68 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1990 | 200 | 0.000 |
Why?
|
| Alleles | 1 | 1990 | 352 | 0.000 |
Why?
|
| Mutation | 1 | 1990 | 1169 | 0.000 |
Why?
|
| Carrier Proteins | 1 | 1982 | 318 | 0.000 |
Why?
|
| Nitrohydroxyiodophenylacetate | 1 | 1979 | 1 | 0.000 |
Why?
|
| Flagellin | 1 | 1979 | 18 | 0.000 |
Why?
|